Renal replacement strategies: dual benefits of hydrogen gas inhalation and hydrogen-enriched dialysate.
Ryoichi Nakazawa, Shintaro Nagami, Hiroshi Nozaki, Minako Yataka, Yoji Inada, Kazuhiro Akiyama, Takashi Uchino, Nakanobu Azuma · Medical gas research · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 300 participants with correspondingly higher plasma ORP levels compared with control subjects, by investigating this novel approach, the researchers aim to contribute to the growing body of evidence supporting the integration of H₂ into RRT for improved patient outcomes. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence blood-pressure regulation.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in 300 participants with correspondingly higher plasma ORP levels compared with control subjects. By investigating this novel approach, the researchers aim to contribute to the growing body of evidence supporting the integration of H₂ into RRT for improved patient outcomes.
What the Researchers Studied
The researchers studied 300 participants with correspondingly higher plasma ORP levels compared with control subjects. The study used a human clinical study. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
2.5% inhaled H₂ concentration; 250 mL/min H₂ output. By investigating this novel approach, the researchers aim to contribute to the growing body of evidence supporting the integration of H₂ into RRT for improved patient outcomes. The authors concluded that however, further research is essential to optimize treatment protocols, ensure safety, and develop comprehensive clinical guidelines for the widespread adoption of this therapy.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence blood-pressure regulation and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 300 participants with correspondingly higher plasma ORP levels compared with control subjects. The study used a human clinical study. The hydrogen delivery method was inhaled hydrogen gas. The reported hydrogen concentration was 2.5% inhaled H₂ concentration.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://europepmc.org/article/PMC/PMC12054674.